Aplenzin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background
Depressive disorders, specifically major depressive disorder (MDD), is predicted to become the leading cause of…
Bupropion was recently marketed as a hydrobromide salt for the treatment of major depressive disorder under the trade name…
Aplenzin is a new drug from Biovail Corp. that has been approved to treat depression in adults